An enzyme assay shows: with inhibitor present, Vmax drops from 100 to 50 μM/s, but Km stays unchanged at 2 mM. A researcher triples the substrate concentration hoping to restore activity. What happens?
AActivity fully restores to 100 μM/s — high substrate concentration always overcomes inhibition
BActivity partially restores but cannot reach 100 μM/s under any substrate concentration
CActivity does not restore — the unchanged Km signals noncompetitive inhibition, which substrate cannot overcome
DActivity drops further — excess substrate worsens noncompetitive inhibition
Unchanged Km with reduced Vmax is the kinetic signature of pure noncompetitive inhibition. The inhibitor binds at an allosteric site separate from the active site, with equal affinity for the free enzyme (E) and the enzyme-substrate complex (ES). Adding substrate fills the active site but cannot touch the inhibitor's binding site. The inhibitor-bound enzyme forms (EI and ESI) remain catalytically inactive regardless of substrate concentration. The new, lower Vmax is the ceiling — a contrast with competitive inhibition, where excess substrate *can* restore activity by outcompeting the inhibitor for the active site.
Question 2 Multiple Choice
On a Lineweaver-Burk plot (1/v vs. 1/[S]), an inhibitor shifts the y-intercept upward but leaves the x-intercept unchanged. What type of inhibition is this?
ACompetitive inhibition — the x-intercept is unchanged, so Km is unaffected
BNoncompetitive inhibition — the y-intercept increases (lower Vmax) while the x-intercept is unchanged (same Km)
CUncompetitive inhibition — both intercepts should shift in the same direction
DMixed inhibition — when both Vmax and apparent Km change simultaneously
On a Lineweaver-Burk plot, the y-intercept equals 1/Vmax and the x-intercept equals −1/Km. An unchanged x-intercept means Km is unchanged (substrate binding affinity unaffected); a higher y-intercept means Vmax is reduced (catalytic efficiency decreased). This pattern is the hallmark of pure noncompetitive inhibition. Competitive inhibition does the opposite: the x-intercept changes (higher apparent Km) while the y-intercept stays the same. Uncompetitive and mixed inhibition produce different patterns with both intercepts shifting.
Question 3 True / False
In noncompetitive inhibition, adding excess substrate can partially restore enzyme velocity because the inhibitor is expected to eventually be displaced from its binding site.
TTrue
FFalse
Answer: False
This misconception imports competitive inhibition logic into a different mechanism. Noncompetitive inhibitors bind at an allosteric site entirely separate from the active site, so there is no competition between substrate and inhibitor — they bind different pockets and can occupy the enzyme simultaneously. Adding substrate increases occupancy of the active site but has no effect on the inhibitor's binding site. The fraction of inhibitor-bound enzyme (EI + ESI) remains constant regardless of substrate concentration, and that fraction is permanently catalytically inactive.
Question 4 True / False
Noncompetitive inhibitors bind equally well to the free enzyme (E) and the enzyme-substrate complex (ES), which is why Km remains unchanged in pure noncompetitive inhibition.
TTrue
FFalse
Answer: True
This equal-affinity binding is the defining feature of pure noncompetitive inhibition. If the inhibitor bound only free enzyme and not ES, it would reduce the effective enzyme pool in a substrate-dependent way, altering the apparent Km (this is mixed inhibition). Because the inhibitor binds E and ES with the same dissociation constant, substrate binding is completely unaffected — the active site geometry and substrate affinity are unchanged. The inhibitor simply renders a fixed fraction of all enzyme forms (both E and ES) catalytically incompetent, reducing Vmax without touching Km.
Question 5 Short Answer
Why can noncompetitive inhibition not be overcome by adding more substrate, and how does this mechanistically differ from competitive inhibition?
Think about your answer, then reveal below.
Model answer: Noncompetitive inhibitors bind at an allosteric site distinct from the substrate binding site, with equal affinity for both free enzyme and the enzyme-substrate complex. Since the inhibitor and substrate occupy different sites, increasing substrate concentration does not displace the inhibitor. In competitive inhibition, both inhibitor and substrate compete for the same active site, so flooding with substrate can outcompete the inhibitor and restore velocity.
In competitive inhibition, inhibitor and substrate are literally competing for the same pocket — probability determines occupancy, so high substrate concentrations shift the odds toward substrate and restore Vmax. In noncompetitive inhibition, there is no competition: substrate and inhibitor bind different sites and can coexist on the same enzyme molecule. The ESI complex is catalytically dead weight, and no amount of substrate can reach or displace the inhibitor. This makes noncompetitive inhibitors particularly useful as drugs: their suppression of enzyme activity is sustained regardless of fluctuating substrate levels in the body.